Home › Funds › Point72 Asset Management › ABCL
Point72 Asset Management position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
Latest position (Q1 2026)1.15M sh
Reported value held$4.01M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 272.98K | $5.47M | New |
| Q2 2023 | 3.96K | $25.58K | New |
| Q4 2025 | 976.51K | $3.34M | New |
| Q1 2026 | 1.15M | $4.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABCL
- Capital World Investors 13.59M sh · $106.67M · Q2 2026
- Two Sigma Investments 10.44M sh · $81.93M · Q2 2026
- Bank of America Corp 6.14M sh · $48.21M · Q2 2026
- BlackRock Inc 3.81M sh · $29.87M · Q2 2026
- Citadel Advisors 2.75M sh · $21.58M · Q2 2026
- UBS Group AG 2.07M sh · $16.25M · Q2 2026
- Marshall Wace 1.90M sh · $14.93M · Q2 2026
- Morgan Stanley 1.67M sh · $13.10M · Q2 2026
- Arrowstreet Capital 1.04M sh · $8.16M · Q2 2026
- Renaissance Technologies 990.93K sh · $7.78M · Q2 2026
- Millennium Management 518.57K sh · $4.07M · Q2 2026
- Geode Capital Management 315.72K sh · $2.48M · Q2 2026